See All Slides - tctmd.com

Slides

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presenter: Mary Acosta

February 12, 2025

Presentation THT 2025

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

Presenter: Jozef Bartunek

February 12, 2025

Presentation THT 2025

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Presenter: Ralph von Bardeleben

February 12, 2025

Presentation THT 2025

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT 2025

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Presenter: Jeffrey Teuteberg

February 12, 2025

Presentation THT 2025

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Presenter: Joao Cavalcante

February 12, 2025

Presentation THT 2025

Trials and Tribulations of Xeno-Transplant

Presenter: Albert Hicks

February 12, 2025

Presentation THT 2025

A Real-World Survey-Based Study on the Characteristics and Treatment Patterns of People With Transthyretin Amyloid Polyneuropathy

Presenter: Klas Rikner

February 12, 2025

Advertisement

Slides

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Trials and Tribulations of Xeno-Transplant

A Real-World Survey-Based Study on the Characteristics and Treatment Patterns of People With Transthyretin Amyloid Polyneuropathy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content